-
effectivehealthcare.ahrq.gov/products/benefits-harms-modeling
November 09, 2009 - Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests – Uses and Limitations … November 09, 2009
Research Report
Decision-Analytic Modeling to Evaluate
-
effectivehealthcare.ahrq.gov/products/asthma-immunotherapy-2011
February 01, 2011 - Development of Quality Criteria To Evaluate Nontherapeutic Studies of Incidence, Prevalence, or Risk … February 01, 2011
Research Report
Development of Quality Criteria To Evaluate
-
effectivehealthcare.ahrq.gov/products/social-isolation/rapid-product
February 11, 2019 - Purpose of Review
To rapidly evaluate the effect of interventions targeting social isolation/loneliness … We used rapid review methods to evaluate recent research. … Health systems should rigorously evaluate their efforts to increase the evidence base and share results
-
effectivehealthcare.ahrq.gov/products/mental-illness-outcomes/technical-brief
January 15, 2015 - Provisions of the Affordable Care Act (2010) require the use of validated quality measures (QMs) to evaluate … Outcomes against which to evaluate the effectiveness of QMs are difficult to measure. … and outcomes; (3) considering when to invest the time and resources on measuring outcomes of care to evaluate
-
effectivehealthcare.ahrq.gov/products/nsaids-safety-data-mining/research
December 02, 2009 - Abstract
Introduction
Bayesian data mining methods have been used to evaluate drug safety signals … Empirical Bayes MGPS algorithm was used to simultaneously evaluate 259 outcomes associated with current … For comparison, a parallel analysis used traditional epidemiologic methods to evaluate the relationship … Discussion
Bayesian data mining methods seem useful to evaluate drug safety using administrative data
-
effectivehealthcare.ahrq.gov/products/coronary-artery-stenting/research
February 26, 2013 - guide and optimize stent deployment; (c) to assess whether stent placement was successful; and (d) to evaluate … use of intravascular diagnostic techniques immediately after percutaneous coronary interventions to evaluate … There is insufficient evidence to evaluate the comparative effect of intravascular diagnostic techniques … studies will need to focus on women and on patients with more severe coronary artery disease, and to evaluate … Further research is also needed to evaluate the use of hybrid and novel intravascular diagnostic techniques
-
effectivehealthcare.ahrq.gov/sites/default/files/assessing-quality-quiz.ppt
September 02, 2013 - Reviewers should identify study design, evaluate general and design-specific sources of bias based on … Reviewers should identify study design, evaluate general and design-specific sources of bias based on … In choosing a tool to evaluate quality, what is the most important consideration? … What Are the Best Tools To Evaluate Quality? … In choosing a tool to evaluate quality, what is the most important consideration?
Incorrect.
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/mental-health-apps
July 17, 2020 - The means for consumers to evaluate digital health applications for mental health disorders. … AHRQ should focus an evidence review on strategies to help evaluate and select a health app that will … An AHRQ evidence report on existing or potential tools to evaluate apps for mental health would be of
-
effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/technical-brief
October 01, 2014 - Structured Abstract
Background
Although multiple imaging modalities to evaluate treatment response … From the published literature, we abstracted data on the types of imaging used to evaluate treatment
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/management-vestibular-schwannomas
June 11, 2021 - Question 1: What is the expected diagnostic yield for vestibular schwannomas when using an MRI to evaluate … Question 2: What is the expected diagnostic yield for vestibular schwannomas when using an MRI to evaluate … Question 3: What is the expected diagnostic yield for vestibular schwannomas when using an MRI to evaluate … Management of Patients with Vestibular Schwannomas
Question 1: What sequences should be obtained on MRI to evaluate … certain areas will be asked to recuse themselves from writing on those areas and will be assigned to evaluate
-
effectivehealthcare.ahrq.gov/products/juvenile-arthritis-dmards/research
September 26, 2011 - Review Methods
To evaluate efficacy, we included prospective trials that included a comparator and … Conclusions
Few data are available to evaluate the comparative effectiveness of either specific DMARDs … Future trials are needed to evaluate the effectiveness of DMARDs against both conventional therapy and
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - Congress, was to evaluate the evidence on benefits
and harms of cannabinoids and similar plant-based … • Longitudinal studies on opioids to evaluate
longer-term outcomes, including associated
harms … Study Design
• Explanatory and pragmatic trials with long-term
follow up to evaluate differential … • Explanatory and pragmatic trials with long-term
followup to evaluate differential effectiveness … Study Design
• Longitudinal explanatory and pragmatic trials to
evaluate effectiveness and safety
-
effectivehealthcare.ahrq.gov/products/methods-prioritization-harms/methods
February 02, 2018 - assessment and reporting of harms is often suboptimal, 1 , 2 the duration of studies is often too short to evaluate … important long-term harms and have inadequate statistical power to evaluate serious but uncommon harms … 8 Issues addressed by the Workgroup included the need to consider a broad range of data sources to evaluate … as published data; the importance of using consistent and precise terminology on harms; the need to evaluate
-
effectivehealthcare.ahrq.gov/products/breast-cancer-imaging/research-protocol
December 17, 2013 - Clinical Excellence (NICE), evidence regarding the accuracy and effectiveness of these modalities to evaluate … We will also evaluate whether certain imaging technologies may be more suitable for some subpopulations … Overview of Different Imaging Modalities Currently Used to Evaluate Treatment of Metastatic Breast Cancer … Context in which Different Imaging Modalities are Currently Used to Evaluate Treatment of Metastatic … What are the major trends in imaging to evaluate treatment for the metastatic breast cancer population
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-imaging_research-protocol.pdf
December 17, 2013 - Clinical
Excellence (NICE), evidence regarding the accuracy and effectiveness of these modalities to evaluate … We
will also evaluate whether certain imaging technologies may be more suitable for some
subpopulations … Context in which Different Imaging Modalities are Currently
Used to Evaluate Treatment of Metastatic … What are the major trends in imaging to evaluate treatment for the metastatic
breast cancer population … What are the major trends in imaging to evaluate treatment for the metastatic
breast cancer population
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/benefits-harms-modeling_research.pdf
November 19, 2009 - Modeling to evaluate benefits and harms of new diagnostic tests compared to established diagnostic tests … – uses and limitations
Medical Tests—White Paper Series
Decision-Analytic Modeling to Evaluate … Decision-
analytic modelling to evaluate benefits and harms of medical tests: uses and limitations. … Decision-analytic modelling to evaluate
benefits and harms of medical tests. … pageaction=displayproduct&productid=350
i
Decision-Analytic Modeling to Evaluate
Benefits
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
September 01, 2021 - function as well as pain, include rigorous evaluation of harms,
evaluate longer-term outcomes, and … evaluate how benefits and harms according to
demographic, clinical, and technical factors. … 2
Background and Purpose
The purpose of this systematic review is to evaluate the effectiveness … function as well as pain, include rigorous evaluation of harms,
evaluate longer-term outcomes, and … evaluate how benefits and harms according to
demographic (age, sex, race/ethnicity), clinical (pain
-
effectivehealthcare.ahrq.gov/system/files/docs/topic-brief-digital-apps-mental-health.pdf
October 29, 2020 - We also found resources that identify characteristics of apps that are evaluated by tools that
evaluate … Summary of Search Findings
We found eight tools that evaluate mental health apps. … Developers of a technical brief would
evaluate these, and other tools identified through broader searches … Assessment of each
criteria determined the need to evaluate the next one. … Developers of a technical brief would evaluate these, and other tools identified through broader searches
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary.pdf
September 01, 2021 - function as well as pain, include rigorous evaluation of harms,
evaluate longer-term outcomes, and … evaluate how benefits and harms according to
demographic, clinical, and technical factors. … 2
Background and Purpose
The purpose of this systematic review is to evaluate the effectiveness … function as well as pain, include rigorous evaluation of harms,
evaluate longer-term outcomes, and … evaluate how benefits and harms according to
demographic (age, sex, race/ethnicity), clinical (pain
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-247-interventional-treatments-acute-chronic-pain-evidence-summary_0.pdf
September 01, 2021 - function as well as pain, include rigorous evaluation of harms,
evaluate longer-term outcomes, and … evaluate how benefits and harms according to
demographic, clinical, and technical factors. … 2
Background and Purpose
The purpose of this systematic review is to evaluate the effectiveness … function as well as pain, include rigorous evaluation of harms,
evaluate longer-term outcomes, and … evaluate how benefits and harms according to
demographic (age, sex, race/ethnicity), clinical (pain